Tower Research Capital »

Lakewood-amedex Biotherapeut shares owned by Tower Research Capital

Quarter-by-quarter ownership of Lakewood-amedex Biotherapeut shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Lakewood-amedex Biotherapeut

Tip: Access up to 7 years of quarterly data

All positions including Lakewood-amedex Biotherapeut held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lakewood-amedex Biotherapeut by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0k 624 3.14

More positions owned by Tower Research Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Spdr Series Trust St Inter Bd Etf (SPIB)
Micron Technology (MU)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Intel Corporation (INTC)
Ishares Tr 0-3 Mth Treasury (SGOV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Tower Research Capital

Top funds holding Lakewood-amedex Biotherapeut

Marex Group
Hrt Financial
UBS Group
Tower Research Capital
Advisor Group Holdings
Ronald Blue Trust

View all funds holding Lakewood-amedex Biotherapeut